Please assess the completion status of the following clinical trial:

Trial Title: Effect of Minocycline on Delirium Incidence in Critically Ill Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical or surgical patients,~* Over 18 years,~* Expected ICU stay of at least 2 days estimated by the attending intensivist,~* Agree to participate in the study~Exclusion Criteria:~* Delirium prior to inclusion,~* Diagnosis of Parkinson's disease~* Diagnosis of dementia,~* Alcohol abuse history,~* Acute neurological condition at admission~* History of psychiatric disease~* Use of antipsychotics~* Pregnant or breastfeeding women,~* Expectation of death within 2 days~* Hospitalized for exclusive palliative care~* Known allergy to minocycline

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Minocycline (Type: EXPERIMENTAL): Minocycline 100 mg BID
- Placebo (Type: PLACEBO_COMPARATOR): Placebo capsules identical to experimental arm

Based on this trial design, predict the completion outcome and termination type (if applicable).